Vorinostat 100 mg Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 100 mg
Reference Brands: Zolinza (USA/EU), Vornat (India)
Category: Oncology Cancer Care
Vorinostat is a Oncology Cancer Care product available as Capsules in strengths 100 mg. It corresponds to the reference brands Zolinza (USA/EU), Vornat (India). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.
Product Description:
Vorinostat is an anticancer medication used in the treatment of cutaneous T-cell lymphoma (CTCL), a rare type of non-Hodgkin lymphoma that primarily affects the skin. It is generally prescribed for patients whose disease persists, worsens, or returns during or after treatment with other therapies. Vorinostat has demonstrated effectiveness in controlling disease progression and improving symptoms in patients with advanced or treatment-resistant CTCL.
Vorinostat belongs to a class of medicines known as histone deacetylase (HDAC) inhibitors. These drugs work by altering gene expression within cancer cells, which can slow the growth of malignant cells, stop their proliferation, and promote programmed cell death (apoptosis). Through this targeted mechanism, Vorinostat helps disrupt the survival and expansion of cancerous T-cells.
The drug is considered a significant advancement in the management of CTCL due to its efficacy and generally well-tolerated safety profile. In addition to its approved use, Vorinostat is also being studied for potential benefits in the treatment of other types of cancers. Ongoing research is evaluating its role both as a single therapy and in combination with other anticancer treatments to improve outcomes in various malignancies.
Vorinostat — third party manufacturing & bulk supply
Vorinostat 100 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Vorinostat listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Vorinostat →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Vorinostat is used for the treatment of cutaneous T-cell lymphoma (CTCL), a rare type of cancer that affects certain white blood cells and primarily involves the skin. It is typically prescribed for patients with progressive, persistent, or recurrent disease after other systemic therapies.
Vorinostat is a synthetic small-molecule anticancer drug that works as a histone deacetylase (HDAC) inhibitor. By inhibiting HDAC enzymes, Vorinostat alters gene expression within cancer cells, which can slow tumor growth, stop cell division, and promote programmed cell death (apoptosis).
The main trade name of Vorinostat is Zolinza.
Vorinostat is developed and marketed by Merck & Co..
The generic name of the medicine sold under the brand Zolinza is Vorinostat.
The primary brand name of Vorinostat is Zolinza.
Vorinostat is manufactured at GMP-certified pharmaceutical facilities operated or authorized by Merck & Co. and its licensed global manufacturing partners in compliance with international regulatory standards such as the US FDA and the European Medicines Agency.
Related Products
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View Details
Idelalisib
Strength:
100 mg, 150 mg
Form: Tablets
Reference Brands: Zydelig (EU/UK/India)
View Details
Inotuzumab Ozogamicin
Strength:
1 mg
Form: Injection
Reference Brands: Besponsa (USA/LATAM)
View DetailsQuick Response Guaranteed | Verified Suppliers
